NCT05636514 2026-03-18
CELESTIAL-MDS
Clinical Hub for Interventional Research (CHOIR)
Phase 1 Recruiting
Clinical Trials
24 trialsNCT06782971 2025-12-08
COSMOS-Avatar
Clinical Hub for Interventional Research (CHOIR)
Recruiting
NCT06793410 2025-06-05
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Vastra Gotaland Region
Phase 2 Recruiting
NCT06299462 2025-02-25
PTCy and ATG for MSD and MUD Transplants
Instituto Nacional de Cancer, Brazil
Phase 1/2 Recruiting
NCT05212103 2024-12-04
CANSI
Turku University Hospital
Enrolling by invitation
NCT02416388 2024-08-07
BIG-1
University Hospital, Angers
Phase 2/3 Recruiting
NCT03493646 2024-05-28
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
Kirby Institute
Phase 2 Completed
NCT04257175 2023-11-28
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
Sheba Medical Center
Phase 2/3 Unknown
NCT04989335 2023-11-28
Bisantrene Combination for Resistant AML
Sheba Medical Center
Phase 2 Unknown
NCT06105658 2023-10-30
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
Anhui Provincial Hospital
Phase 2 Unknown
NCT05149339 2021-12-08
Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia
Zagazig University
Phase 1/2 Completed
NCT04931992 2021-06-18
MOLAM
University Hospital, Angers
Unknown
NCT04240600 2020-09-03
HEMVEF
Hospital General de Mexico
Phase NA Unknown
NCT00342316 2020-01-27
Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
Vastra Gotaland Region
Phase NA Completed
NCT03978364 2019-06-07
A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC
Shandong Provincial Hospital
Phase 3 Unknown
NCT03204838 2017-07-02
IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients
Hospital General de Mexico
Unknown
NCT01542944 2016-04-20
TevaGastrim for Stem Cell Mobilization Sibling Donors
Sheba Medical Center
Phase 2 Completed
NCT00491634 2015-12-02
Treosulfan-based Conditioning for Transplantation in AML/MDS
Sheba Medical Center
Phase 2 Completed
NCT02275663 2015-01-06
Azacytidine Plus FLAG for Relapsed or Refractory AML
King Fahad Medical City
Phase 2 Unknown
NCT02113319 2014-04-14
DasaCBF
University Hospital, Angers
Phase 2 Completed
NCT00451711 2013-12-16
Intermittent Liposomal Amphotericin B Primary Prophylaxis
Bayside Health
Phase 2 Unknown
NCT00636922 2013-02-15
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
Bayside Health
Phase 1 Unknown
NCT01329471 2011-04-06
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
Hillel Yaffe Medical Center
Unknown
NCT00552825 2007-11-02
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children
Sheba Medical Center
Completed